Tokyo Tape
Sign in
← Nissan Chemical Corporatiom

Annual report

4021.TEDINET S100OIHF
Period2021-04-01 → 2022-03-31
Filed2022-06-28
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 148
MetricValuePeriodScopeSource row
Revenue¥208.0bn2021-04-01 → 2022-03-31Cons.Net sales
Revenue¥209.1bn2020-04-01 → 2021-03-31Cons.Net sales
Revenue¥206.8bn2019-04-01 → 2020-03-31dCons.Net sales (5-year summary)
Revenue¥204.9bn2018-04-01 → 2019-03-31dCons.Net sales (5-year summary)
Revenue¥193.4bn2017-04-01 → 2018-03-31dCons.Net sales (5-year summary)
Operating income¥51.0bn2021-04-01 → 2022-03-31Cons.Operating income
Operating income¥42.5bn2020-04-01 → 2021-03-31Cons.Operating income
Ordinary income¥53.7bn2021-04-01 → 2022-03-31Cons.Ordinary income
Ordinary income¥43.9bn2020-04-01 → 2021-03-31Cons.Ordinary income
Ordinary income¥40.0bn2019-04-01 → 2020-03-31dCons.Ordinary income loss (5-year summary)
Ordinary income¥39.1bn2018-04-01 → 2019-03-31dCons.Ordinary income loss (5-year summary)
Ordinary income¥36.2bn2017-04-01 → 2018-03-31dCons.Ordinary income loss (5-year summary)
Profit before tax¥54.2bn2021-04-01 → 2022-03-31Cons.Income before income taxes
Profit before tax¥45.5bn2020-04-01 → 2021-03-31Cons.Income before income taxes
Net income (owners)¥38.8bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥33.5bn2020-04-01 → 2021-03-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥30.8bn2019-04-01 → 2020-03-31dCons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥29.4bn2018-04-01 → 2019-03-31dCons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥27.1bn2017-04-01 → 2018-03-31dCons.Profit loss attributable to owners of parent (5-year summary)
Net income¥39.1bn2021-04-01 → 2022-03-31Cons.Profit loss
Net income¥33.5bn2020-04-01 → 2021-03-31Cons.Profit loss
Total assets¥279.7bnat 2022-03-31Cons.Assets
Total assets¥265.5bnat 2021-03-31Cons.Assets
Total assets¥249.5bnat 2020-03-31dCons.Total assets (5-year summary)
Total assets¥247.0bnat 2019-03-31dCons.Total assets (5-year summary)
Total assets¥246.0bnat 2018-03-31dCons.Total assets (5-year summary)
Total liabilities¥71.7bnat 2022-03-31Cons.Liabilities
Total liabilities¥64.9bnat 2021-03-31Cons.Liabilities
Net assets / equity¥208.0bnat 2022-03-31Cons.Net assets
Net assets / equity¥200.6bnat 2021-03-31Cons.Net assets
Net assets / equity¥185.5bnat 2020-03-31dCons.Net assets
Net assets / equity¥182.1bnat 2019-03-31dCons.Net assets (5-year summary)
Net assets / equity¥176.4bnat 2018-03-31dCons.Net assets (5-year summary)
Cash and deposits¥34.7bnat 2022-03-31Cons.Cash and deposits
Cash and deposits¥32.4bnat 2021-03-31Cons.Cash and deposits
Cash & equivalents¥34.7bnat 2022-03-31Cons.Cash and cash equivalents
Cash & equivalents¥32.4bnat 2021-03-31Cons.Cash and cash equivalents
Cash & equivalents¥30.6bnat 2020-03-31dCons.Cash and cash equivalents
Cash & equivalents¥36.2bnat 2019-03-31dCons.Cash and cash equivalents (5-year summary)
Cash & equivalents¥37.7bnat 2018-03-31dCons.Cash and cash equivalents (5-year summary)
Operating cash flow¥41.9bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in operating activities
Operating cash flow¥39.9bn2020-04-01 → 2021-03-31Cons.Net cash provided by used in operating activities
Operating cash flow¥35.5bn2019-04-01 → 2020-03-31dCons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥32.1bn2018-04-01 → 2019-03-31dCons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥37.7bn2017-04-01 → 2018-03-31dCons.Net cash provided by used in operating activities (5-year summary)
Investing cash flow−¥12.4bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥12.9bn2020-04-01 → 2021-03-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥15.6bn2019-04-01 → 2020-03-31dCons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥10.9bn2018-04-01 → 2019-03-31dCons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥15.2bn2017-04-01 → 2018-03-31dCons.Net cash provided by used in investing activities (5-year summary)
Financing cash flow−¥27.9bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in financing activities
Financing cash flow−¥25.6bn2020-04-01 → 2021-03-31Cons.Net cash provided by used in financing activities
Financing cash flow−¥25.2bn2019-04-01 → 2020-03-31dCons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥22.6bn2018-04-01 → 2019-03-31dCons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥20.3bn2017-04-01 → 2018-03-31dCons.Net cash provided by used in financing activities (5-year summary)
EPS (basic)¥271.882021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥231.732020-04-01 → 2021-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥210.092019-04-01 → 2020-03-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥197.672018-04-01 → 2019-03-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥180.32017-04-01 → 2018-03-31dCons.Basic earnings loss per share (5-year summary)
Net assets per share¥1,454.01at 2022-03-31Cons.Net assets per share (5-year summary)
Net assets per share¥1,384.13at 2021-03-31Cons.Net assets per share (5-year summary)
Net assets per share¥1,264.23at 2020-03-31dCons.Net assets per share (5-year summary)
Net assets per share¥1,220.35at 2019-03-31dCons.Net assets per share (5-year summary)
Net assets per share¥1,168.07at 2018-03-31dCons.Net assets per share (5-year summary)
Equity ratio73.6%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio74.9%at 2021-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio73.7%at 2020-03-31dCons.Equity to asset ratio (5-year summary)
Equity ratio73.0%at 2019-03-31dCons.Equity to asset ratio (5-year summary)
Equity ratio71.0%at 2018-03-31dCons.Equity to asset ratio (5-year summary)
ROE19.2%2021-04-01 → 2022-03-31Cons.Rate of return on equity (5-year summary)
ROE17.5%2020-04-01 → 2021-03-31Cons.Rate of return on equity (5-year summary)
ROE16.9%2019-04-01 → 2020-03-31dCons.Rate of return on equity (5-year summary)
ROE16.6%2018-04-01 → 2019-03-31dCons.Rate of return on equity (5-year summary)
ROE16.1%2017-04-01 → 2018-03-31dCons.Rate of return on equity (5-year summary)
Employees2,737at 2022-03-31Cons.Number of employees
Employees2,688at 2021-03-31Cons.Number of employees
Employees2,640at 2020-03-31dCons.Number of employees
Employees2,583at 2019-03-31dCons.Number of employees
Employees2,511at 2018-03-31dCons.Number of employees
Revenue¥170.0bn2021-04-01 → 2022-03-31StandaloneNet sales
Revenue¥162.5bn2020-04-01 → 2021-03-31StandaloneNet sales
Revenue¥160.2bn2019-04-01 → 2020-03-31dStandaloneNet sales (5-year summary)
Revenue¥156.1bn2018-04-01 → 2019-03-31dStandaloneNet sales (5-year summary)
Revenue¥147.3bn2017-04-01 → 2018-03-31dStandaloneNet sales (5-year summary)
Operating income¥42.5bn2021-04-01 → 2022-03-31StandaloneOperating income
Operating income¥37.3bn2020-04-01 → 2021-03-31StandaloneOperating income
Ordinary income¥46.5bn2021-04-01 → 2022-03-31StandaloneOrdinary income
Ordinary income¥39.3bn2020-04-01 → 2021-03-31StandaloneOrdinary income
Ordinary income¥37.5bn2019-04-01 → 2020-03-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥36.2bn2018-04-01 → 2019-03-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥32.9bn2017-04-01 → 2018-03-31dStandaloneOrdinary income loss (5-year summary)
Profit before tax¥46.6bn2021-04-01 → 2022-03-31StandaloneIncome before income taxes
Profit before tax¥40.9bn2020-04-01 → 2021-03-31StandaloneIncome before income taxes
Net income¥34.4bn2021-04-01 → 2022-03-31StandaloneProfit loss
Net income¥30.7bn2020-04-01 → 2021-03-31StandaloneProfit loss
Net income¥29.6bn2019-04-01 → 2020-03-31dStandaloneNet income loss (5-year summary)
Net income¥28.0bn2018-04-01 → 2019-03-31dStandaloneNet income loss (5-year summary)
Net income¥25.4bn2017-04-01 → 2018-03-31dStandaloneNet income loss (5-year summary)
Total assets¥231.0bnat 2022-03-31StandaloneAssets
Total assets¥225.6bnat 2021-03-31StandaloneAssets
Total assets¥213.2bnat 2020-03-31dStandaloneTotal assets (5-year summary)
Total assets¥210.1bnat 2019-03-31dStandaloneTotal assets (5-year summary)
Total assets¥208.7bnat 2018-03-31dStandaloneTotal assets (5-year summary)
Total liabilities¥62.7bnat 2022-03-31StandaloneLiabilities
Total liabilities¥59.9bnat 2021-03-31StandaloneLiabilities
Net assets / equity¥168.4bnat 2022-03-31StandaloneNet assets
Net assets / equity¥165.6bnat 2021-03-31StandaloneNet assets
Net assets / equity¥155.4bnat 2020-03-31dStandaloneNet assets
Net assets / equity¥151.8bnat 2019-03-31dStandaloneNet assets (5-year summary)
Net assets / equity¥147.2bnat 2018-03-31dStandaloneNet assets (5-year summary)
Cash and deposits¥24.6bnat 2022-03-31StandaloneCash and deposits
Cash and deposits¥26.7bnat 2021-03-31StandaloneCash and deposits
EPS (basic)¥241.212021-04-01 → 2022-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥212.522020-04-01 → 2021-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥201.762019-04-01 → 2020-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥188.132018-04-01 → 2019-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥1692017-04-01 → 2018-03-31dStandaloneBasic earnings loss per share (5-year summary)
Dividend per share¥1222021-04-01 → 2022-03-31StandaloneDividend paid per share (5-year summary)
Dividend per share¥1042020-04-01 → 2021-03-31StandaloneDividend paid per share (5-year summary)
Dividend per share¥902019-04-01 → 2020-03-31dStandaloneDividend paid per share (5-year summary)
Dividend per share¥822018-04-01 → 2019-03-31dStandaloneDividend paid per share (5-year summary)
Dividend per share¥682017-04-01 → 2018-03-31dStandaloneDividend paid per share (5-year summary)
Net assets per share¥1,188.84at 2022-03-31StandaloneNet assets per share (5-year summary)
Net assets per share¥1,152.93at 2021-03-31StandaloneNet assets per share (5-year summary)
Net assets per share¥1,068.43at 2020-03-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥1,027.04at 2019-03-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥984.94at 2018-03-31dStandaloneNet assets per share (5-year summary)
Equity ratio72.9%at 2022-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio73.4%at 2021-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio72.9%at 2020-03-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio72.2%at 2019-03-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio70.5%at 2018-03-31dStandaloneEquity to asset ratio (5-year summary)
ROE20.6%2021-04-01 → 2022-03-31StandaloneRate of return on equity (5-year summary)
ROE19.1%2020-04-01 → 2021-03-31StandaloneRate of return on equity (5-year summary)
ROE19.2%2019-04-01 → 2020-03-31dStandaloneRate of return on equity (5-year summary)
ROE18.7%2018-04-01 → 2019-03-31dStandaloneRate of return on equity (5-year summary)
ROE17.9%2017-04-01 → 2018-03-31dStandaloneRate of return on equity (5-year summary)
Shares issued143,000,000at 2022-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued145,000,000at 2021-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued146,000,000at 2020-03-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued149,000,000at 2019-03-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued151,000,000at 2018-03-31dStandaloneTotal number of issued shares (5-year summary)
Employees1,929at 2022-03-31StandaloneNumber of employees
Employees1,924at 2021-03-31StandaloneNumber of employees
Employees1,890at 2020-03-31dStandaloneNumber of employees
Employees1,861at 2019-03-31dStandaloneNumber of employees
Employees1,819at 2018-03-31dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 122
SegmentItemPeriodValue
Otherother segmentscapex2021-04-01 → 2022-03-31¥614m
Otherother segmentsdepreciation2021-04-01 → 2022-03-31¥299m
Otherother segmentsemployeesat 2022-03-31422 pure
Otherother segmentsrevenue2021-04-01 → 2022-03-31¥23.6bn
Otherother segmentsrevenue external2021-04-01 → 2022-03-31¥10.9bn
Otherother segmentsrevenue intersegment2021-04-01 → 2022-03-31¥12.7bn
Otherother segmentssegment assetsat 2022-03-31¥12.2bn
Otherother segmentssegment profit2021-04-01 → 2022-03-31¥692m
Reconciling Itemsreconcilingcapex2021-04-01 → 2022-03-31¥127m
Reconciling Itemsreconcilingdepreciation2021-04-01 → 2022-03-31¥233m
Reconciling Itemsreconcilingrevenue2021-04-01 → 2022-03-31−¥87.8bn
Reconciling Itemsreconcilingrevenue external2021-04-01 → 2022-03-31−¥22.8bn
Reconciling Itemsreconcilingrevenue intersegment2021-04-01 → 2022-03-31−¥65.0bn
Reconciling Itemsreconcilingsegment assetsat 2022-03-31¥49.0bn
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2022-03-31−¥3.4bn
Agrochemicalsreportable segmentcapex2021-04-01 → 2022-03-31¥1.5bn
Agrochemicalsreportable segmentdepreciation2021-04-01 → 2022-03-31¥2.6bn
Agrochemicalsreportable segmentemployeesat 2022-03-31517 pure
Agrochemicalsreportable segmentrevenue2021-04-01 → 2022-03-31¥65.8bn
Agrochemicalsreportable segmentrevenue external2021-04-01 → 2022-03-31¥58.0bn
Agrochemicalsreportable segmentrevenue intersegment2021-04-01 → 2022-03-31¥7.9bn
Agrochemicalsreportable segmentsegment assetsat 2022-03-31¥90.7bn
Agrochemicalsreportable segmentsegment profit2021-04-01 → 2022-03-31¥18.3bn
Chemicalsreportable segmentcapex2021-04-01 → 2022-03-31¥2.3bn
Chemicalsreportable segmentdepreciation2021-04-01 → 2022-03-31¥2.5bn
Chemicalsreportable segmentemployeesat 2022-03-31379 pure
Chemicalsreportable segmentrevenue2021-04-01 → 2022-03-31¥37.6bn
Chemicalsreportable segmentrevenue external2021-04-01 → 2022-03-31¥26.0bn
Chemicalsreportable segmentrevenue intersegment2021-04-01 → 2022-03-31¥11.6bn
Chemicalsreportable segmentsegment assetsat 2022-03-31¥32.1bn
Chemicalsreportable segmentsegment profit2021-04-01 → 2022-03-31¥3.8bn
Performance Materialsreportable segmentcapex2021-04-01 → 2022-03-31¥5.7bn
Performance Materialsreportable segmentdepreciation2021-04-01 → 2022-03-31¥3.9bn
Performance Materialsreportable segmentemployeesat 2022-03-31789 pure
Performance Materialsreportable segmentrevenue2021-04-01 → 2022-03-31¥81.7bn
Performance Materialsreportable segmentrevenue external2021-04-01 → 2022-03-31¥69.7bn
Performance Materialsreportable segmentrevenue intersegment2021-04-01 → 2022-03-31¥12.0bn
Performance Materialsreportable segmentsegment assetsat 2022-03-31¥55.1bn
Performance Materialsreportable segmentsegment profit2021-04-01 → 2022-03-31¥27.7bn
Pharmaceuticalsreportable segmentcapex2021-04-01 → 2022-03-31¥651m
Pharmaceuticalsreportable segmentdepreciation2021-04-01 → 2022-03-31¥541m
Pharmaceuticalsreportable segmentemployeesat 2022-03-31174 pure
Pharmaceuticalsreportable segmentrevenue2021-04-01 → 2022-03-31¥6.6bn
Pharmaceuticalsreportable segmentrevenue external2021-04-01 → 2022-03-31¥6.6bn
Pharmaceuticalsreportable segmentrevenue intersegment2021-04-01 → 2022-03-31¥49m
Pharmaceuticalsreportable segmentsegment assetsat 2022-03-31¥9.2bn
Pharmaceuticalsreportable segmentsegment profit2021-04-01 → 2022-03-31¥947m
Tradingreportable segmentcapex2021-04-01 → 2022-03-31¥20m
Tradingreportable segmentdepreciation2021-04-01 → 2022-03-31¥73m
Tradingreportable segmentemployeesat 2022-03-31179 pure
Tradingreportable segmentrevenue2021-04-01 → 2022-03-31¥80.4bn
Tradingreportable segmentrevenue external2021-04-01 → 2022-03-31¥59.6bn
Tradingreportable segmentrevenue intersegment2021-04-01 → 2022-03-31¥20.8bn
Tradingreportable segmentsegment assetsat 2022-03-31¥31.5bn
Tradingreportable segmentsegment profit2021-04-01 → 2022-03-31¥2.9bn
—segment totalcapex2021-04-01 → 2022-03-31¥10.8bn
—segment totaldepreciation2021-04-01 → 2022-03-31¥9.9bn
—segment totalrevenue2021-04-01 → 2022-03-31¥295.8bn
—segment totalrevenue external2021-04-01 → 2022-03-31¥230.8bn
—segment totalrevenue intersegment2021-04-01 → 2022-03-31¥65.0bn
—segment totalsegment assetsat 2022-03-31¥230.7bn
—segment totalsegment profit2021-04-01 → 2022-03-31¥54.4bn
Otherother segmentscapex2020-04-01 → 2021-03-31¥388m
Otherother segmentsdepreciation2020-04-01 → 2021-03-31¥311m
Otherother segmentsrevenue2020-04-01 → 2021-03-31¥23.8bn
Otherother segmentsrevenue external2020-04-01 → 2021-03-31¥9.7bn
Otherother segmentsrevenue intersegment2020-04-01 → 2021-03-31¥14.1bn
Otherother segmentssegment assetsat 2021-03-31¥12.8bn
Otherother segmentssegment profit2020-04-01 → 2021-03-31¥831m
Reconciling Itemsreconcilingcapex2020-04-01 → 2021-03-31¥296m
Reconciling Itemsreconcilingdepreciation2020-04-01 → 2021-03-31¥191m
Reconciling Itemsreconcilingrevenue2020-04-01 → 2021-03-31−¥58.5bn
Reconciling Itemsreconcilingrevenue external2020-04-01 → 2021-03-31¥12m
Reconciling Itemsreconcilingrevenue intersegment2020-04-01 → 2021-03-31−¥58.5bn
Reconciling Itemsreconcilingsegment assetsat 2021-03-31¥52.3bn
Reconciling Itemsreconcilingsegment profit2020-04-01 → 2021-03-31−¥3.3bn
Agrochemicalsreportable segmentcapex2020-04-01 → 2021-03-31¥6.4bn
Agrochemicalsreportable segmentdepreciation2020-04-01 → 2021-03-31¥2.5bn
Agrochemicalsreportable segmentrevenue2020-04-01 → 2021-03-31¥63.8bn
Agrochemicalsreportable segmentrevenue external2020-04-01 → 2021-03-31¥57.5bn
Agrochemicalsreportable segmentrevenue intersegment2020-04-01 → 2021-03-31¥6.3bn
Agrochemicalsreportable segmentsegment assetsat 2021-03-31¥82.8bn
Agrochemicalsreportable segmentsegment profit2020-04-01 → 2021-03-31¥18.2bn
Chemicalsreportable segmentcapex2020-04-01 → 2021-03-31¥4.9bn
Chemicalsreportable segmentdepreciation2020-04-01 → 2021-03-31¥2.2bn
Chemicalsreportable segmentrevenue2020-04-01 → 2021-03-31¥31.9bn
Chemicalsreportable segmentrevenue external2020-04-01 → 2021-03-31¥21.9bn
Chemicalsreportable segmentrevenue intersegment2020-04-01 → 2021-03-31¥10.0bn
Chemicalsreportable segmentsegment assetsat 2021-03-31¥30.8bn
Chemicalsreportable segmentsegment profit2020-04-01 → 2021-03-31¥1.5bn
Performance Materialsreportable segmentcapex2020-04-01 → 2021-03-31¥3.2bn
Performance Materialsreportable segmentdepreciation2020-04-01 → 2021-03-31¥4.5bn
Performance Materialsreportable segmentrevenue2020-04-01 → 2021-03-31¥71.6bn
Performance Materialsreportable segmentrevenue external2020-04-01 → 2021-03-31¥62.6bn
Performance Materialsreportable segmentrevenue intersegment2020-04-01 → 2021-03-31¥9.0bn
Performance Materialsreportable segmentsegment assetsat 2021-03-31¥51.0bn
Performance Materialsreportable segmentsegment profit2020-04-01 → 2021-03-31¥22.4bn
Pharmaceuticalsreportable segmentcapex2020-04-01 → 2021-03-31¥475m
Pharmaceuticalsreportable segmentdepreciation2020-04-01 → 2021-03-31¥517m
Pharmaceuticalsreportable segmentrevenue2020-04-01 → 2021-03-31¥6.7bn
Pharmaceuticalsreportable segmentrevenue external2020-04-01 → 2021-03-31¥6.6bn
Pharmaceuticalsreportable segmentrevenue intersegment2020-04-01 → 2021-03-31¥43m
Pharmaceuticalsreportable segmentsegment assetsat 2021-03-31¥9.6bn
Pharmaceuticalsreportable segmentsegment profit2020-04-01 → 2021-03-31¥357m
Tradingreportable segmentcapex2020-04-01 → 2021-03-31¥137m
Tradingreportable segmentdepreciation2020-04-01 → 2021-03-31¥80m
Tradingreportable segmentrevenue2020-04-01 → 2021-03-31¥69.8bn
Tradingreportable segmentrevenue external2020-04-01 → 2021-03-31¥50.8bn
Tradingreportable segmentrevenue intersegment2020-04-01 → 2021-03-31¥19.0bn
Tradingreportable segmentsegment assetsat 2021-03-31¥26.2bn
Tradingreportable segmentsegment profit2020-04-01 → 2021-03-31¥2.5bn
—segment totalcapex2020-04-01 → 2021-03-31¥15.5bn
—segment totaldepreciation2020-04-01 → 2021-03-31¥10.2bn
—segment totalrevenue2020-04-01 → 2021-03-31¥267.6bn
—segment totalrevenue external2020-04-01 → 2021-03-31¥209.1bn
—segment totalrevenue intersegment2020-04-01 → 2021-03-31¥58.5bn
—segment totalsegment assetsat 2021-03-31¥213.2bn
—segment totalsegment profit2020-04-01 → 2021-03-31¥45.8bn
Agrochemicalsreportable segmentemployeesat 2022-03-31512 pure
Chemicalsreportable segmentemployeesat 2022-03-31379 pure
Performance Materialsreportable segmentemployeesat 2022-03-31587 pure
Pharmaceuticalsreportable segmentemployeesat 2022-03-31174 pure

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 1,872
ItemContextValueUnit
Number of employeesPrior1YearInstant_NonConsolidatedMember1924
Number of employeesCurrentYearInstant_NonConsolidatedMember1929
Average number of temporary workersPrior4YearInstant_NonConsolidatedMember196
Average number of temporary workersPrior3YearInstant_NonConsolidatedMember206
Average number of temporary workersPrior2YearInstant_NonConsolidatedMember209
Average number of temporary workersPrior1YearInstant_NonConsolidatedMember204
Average number of temporary workersCurrentYearInstant_NonConsolidatedMember207
Total shareholder returnPrior4YearInstant_NonConsolidatedMember1.385
Total shareholder returnPrior3YearInstant_NonConsolidatedMember1.611
Total shareholder returnPrior2YearInstant_NonConsolidatedMember1.290
Total shareholder returnPrior1YearInstant_NonConsolidatedMember1.930
Total shareholder returnCurrentYearInstant_NonConsolidatedMember2.375
Total return on share price indexPrior4YearInstant_NonConsolidatedMember1.159
Total return on share price indexPrior3YearInstant_NonConsolidatedMember1.100
Total return on share price indexPrior2YearInstant_NonConsolidatedMember0.996
Total return on share price indexPrior1YearInstant_NonConsolidatedMember1.415
Total return on share price indexCurrentYearInstant_NonConsolidatedMember1.443
Number of employeesCurrentYearInstant_jpcrp030000-asr_E00759-000ChemicalsReportableSegmentsMember379
Number of employeesCurrentYearInstant_jpcrp030000-asr_E00759-000PerformanceMaterialsReportableSegmentsMember789
Number of employeesCurrentYearInstant_jpcrp030000-asr_E00759-000AgrochemicalsReportableSegmentsMember517
Number of employeesCurrentYearInstant_jpcrp030000-asr_E00759-000PharmaceuticalsReportableSegmentsMember174
Number of employeesCurrentYearInstant_jpcrp030000-asr_E00759-000TradingReportableSegmentsMember179
Number of employeesCurrentYearInstant_OtherReportableSegmentsMember422
Number of employeesCurrentYearInstant_CorporateSharedMember277
Number of employeesCurrentYearInstant2737
Average number of temporary workersCurrentYearInstant_ReportableSegmentsMember336
Number of employeesCurrentYearInstant_NonConsolidatedMember1929
Average number of temporary workersCurrentYearInstant_NonConsolidatedMember207
Average age years information about reporting company information about employeesCurrentYearInstant_NonConsolidatedMember40.2
Average length of service years information about reporting company information about employeesCurrentYearInstant_NonConsolidatedMember15.8
Average annual salary information about reporting company information about employeesCurrentYearInstant_NonConsolidatedMember8147376JPY
Number of employeesCurrentYearInstant_NonConsolidatedMember_jpcrp030000-asr_E00759-000ChemicalsReportableSegmentsMember379
Number of employeesCurrentYearInstant_NonConsolidatedMember_jpcrp030000-asr_E00759-000PerformanceMaterialsReportableSegmentsMember587
Number of employeesCurrentYearInstant_NonConsolidatedMember_jpcrp030000-asr_E00759-000AgrochemicalsReportableSegmentsMember512
Number of employeesCurrentYearInstant_NonConsolidatedMember_jpcrp030000-asr_E00759-000PharmaceuticalsReportableSegmentsMember174
Number of employeesCurrentYearInstant_NonConsolidatedMember_CorporateSharedMember277
Number of employeesCurrentYearInstant_NonConsolidatedMember1929
Average number of temporary workersCurrentYearInstant_NonConsolidatedMember_ReportableSegmentsMember207
Research and development expenses research and development activitiesCurrentYearDuration16023000000JPY
Research and development expenses research and development activitiesCurrentYearDuration_jpcrp030000-asr_E00759-000ChemicalsReportableSegmentsMember290000000JPY
Research and development expenses research and development activitiesCurrentYearDuration_jpcrp030000-asr_E00759-000PerformanceMaterialsReportableSegmentsMember7037000000JPY
Research and development expenses research and development activitiesCurrentYearDuration_jpcrp030000-asr_E00759-000AgrochemicalsReportableSegmentsMember4204000000JPY
Research and development expenses research and development activitiesCurrentYearDuration_jpcrp030000-asr_E00759-000PharmaceuticalsReportableSegmentsMember2125000000JPY
Capital expenditures overview of capital expenditures etcCurrentYearDuration10951000000JPY
Capital expenditures overview of capital expenditures etcCurrentYearDuration_jpcrp030000-asr_E00759-000ChemicalsReportableSegmentsMember5725000000JPY
Number of issued shares as of fiscal year end issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember143000000
Number of issued shares as of filing date issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember142000000
Number of issued shares as of fiscal year end issued shares total number of shares etcFilingDateInstant143000000
Number of issued shares as of filing date issued shares total number of shares etcFilingDateInstant142000000
Number of shares constituting one unitCurrentYearInstant_OrdinaryShareMember100

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 24 of 24 passed
balance sheet identityconsolidated 2021-03-31pass
balance sheet identityconsolidated 2022-03-31pass
balance sheet identitynon_consolidated 2021-03-31pass
balance sheet identitynon_consolidated 2022-03-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2020-03-31pass
statement vs summary · net assetsconsolidated 2021-03-31pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsnon_consolidated 2020-03-31pass
statement vs summary · net assetsnon_consolidated 2021-03-31pass
statement vs summary · net assetsnon_consolidated 2022-03-31pass
statement vs summary · net income attributable to parentconsolidated 2020-04-01/2021-03-31pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2022-03-31pass
statement vs summary · operating cash flowconsolidated 2020-04-01/2021-03-31pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2022-03-31pass
statement vs summary · revenueconsolidated 2020-04-01/2021-03-31pass
statement vs summary · revenueconsolidated 2021-04-01/2022-03-31pass
statement vs summary · revenuenon_consolidated 2020-04-01/2021-03-31pass
statement vs summary · revenuenon_consolidated 2021-04-01/2022-03-31pass
statement vs summary · total assetsconsolidated 2021-03-31pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsnon_consolidated 2021-03-31pass
statement vs summary · total assetsnon_consolidated 2022-03-31pass